Boronic Acid-Containing 3<i>H</i>- pyrazolo[4,3-<i>f</i>]quinoline Compounds as Dual CLK/ROCK Inhibitors with Anticancer Properties
<b>Background:</b> The protein kinases CLK and ROCK play key roles in cell growth and migration, respectively, and are potential anticancer targets. ROCK inhibitors have been approved by the FDA for various diseases and CLK inhibitors are currently being trialed in the clinic as anticanc...
Saved in:
| Main Authors: | Neetu Dayal, Riddhi Chaudhuri, Kofi Simpa Yeboah, Nickolas R. Brauer, Herman O. Sintim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/17/12/1660 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression
by: Jasper Van Goubergen, et al.
Published: (2025-02-01) -
Network Pharmacology and Molecular Docking Reveal Anti-Asthmatic Potential of <i>Zephyranthes rosea</i> Lindl. in an Ovalbumin-Induced Asthma Model
by: Amir Ali, et al.
Published: (2024-11-01) -
The pyrazolo[4,3-c]pyrazole core as a novel and versatile scaffold for developing dual DYRK1A-CLK1 inhibitors targeting key processes of Alzheimer's disease pathology
by: Vaia-Argyro Bakalakou, et al.
Published: (2024-12-01) -
Efficient construction of a quinoline framework from alcohols, nitroarenes, and alkenes promoted by a trimetallic catalyst system
by: Rikiya Horikawa, et al.
Published: (2024-12-01) -
Efficacy and safety of tyrosine kinase inhibitors with thoracic radiotherapy for patients with oncogene-mutated non-small cell lung cancer: a meta-analysis
by: Wenxia Li, et al.
Published: (2024-11-01)